These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 38581025)
41. Overexpression of negative regulator of ubiquitin-like proteins 1 (NUB1) inhibits proliferation and invasion of gastric cancer cells through upregulation of p27Kip1 and inhibition of epithelial-mesenchymal transition. Zhang D; Wu P; Zhang Z; An W; Zhang C; Pan S; Tan Y; Xu H Pathol Res Pract; 2020 Aug; 216(8):153002. PubMed ID: 32703484 [TBL] [Abstract][Full Text] [Related]
42. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway. Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047 [TBL] [Abstract][Full Text] [Related]
43. Effects of microRNA-378 on epithelial-mesenchymal transition, migration, invasion and prognosis in gastric carcinoma by targeting BMP2. Yang YJ; Luo S; Wang LS Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5176-5186. PubMed ID: 31298369 [TBL] [Abstract][Full Text] [Related]
44. Wang G; Sun D; Li W; Xin Y Biomed Res Int; 2020; 2020():6726759. PubMed ID: 32462010 [TBL] [Abstract][Full Text] [Related]
45. High expression of hnRNPA1 promotes cell invasion by inducing EMT in gastric cancer. Chen Y; Liu J; Wang W; Xiang L; Wang J; Liu S; Zhou H; Guo Z Oncol Rep; 2018 Apr; 39(4):1693-1701. PubMed ID: 29484423 [TBL] [Abstract][Full Text] [Related]
46. RHOJ Induces Epithelial-to-Mesenchymal Transition by IL-6/STAT3 to Promote Invasion and Metastasis in Gastric Cancer. Ma Z; Sun Q; Zhang C; Zheng Q; Liu Y; Xu H; He Y; Yao C; Chen J; Xia H Int J Biol Sci; 2023; 19(14):4411-4426. PubMed ID: 37781036 [No Abstract] [Full Text] [Related]
47. KNTC1 functions as a potential biomarker and oncogene regulating proliferation, migration and apoptosis in gastric cancer. Qi H; Cao M; Chen Y; Li X; Wang Y; Dai X; Duan X; Lu J Int Immunopharmacol; 2024 Dec; 143(Pt 1):113257. PubMed ID: 39362011 [TBL] [Abstract][Full Text] [Related]
48. CALD1 facilitates epithelial-mesenchymal transition progression in gastric cancer cells by modulating the PI3K-Akt pathway. Ma WQ; Miao MC; Ding PA; Tan BB; Liu WB; Guo S; Er LM; Zhang ZD; Zhao Q World J Gastrointest Oncol; 2024 Mar; 16(3):1029-1045. PubMed ID: 38577446 [TBL] [Abstract][Full Text] [Related]
49. miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression. Song G; Zhang H; Chen C; Gong L; Chen B; Zhao S; Shi J; Xu J; Ye Z Oncotarget; 2017 Jul; 8(28):45725-45735. PubMed ID: 28501849 [TBL] [Abstract][Full Text] [Related]
50. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway. Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138 [TBL] [Abstract][Full Text] [Related]
51. SMC1A facilitates gastric cancer cell proliferation, migration, and invasion via promoting SNAIL activated EMT. Liu Y; Fang X; Wang Q; Xiao D; Zhou T; Kang K; Peng Z; Ren F; Zhou J BMC Gastroenterol; 2023 Aug; 23(1):268. PubMed ID: 37537540 [TBL] [Abstract][Full Text] [Related]
52. Increased UBD Is a Potential Diagnostic and Prognostic Biomarker in Glioma. Wu T; Du M; Zeng L; Wang H; Li X Environ Toxicol; 2024 Dec; 39(12):5250-5263. PubMed ID: 39155575 [TBL] [Abstract][Full Text] [Related]
53. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway. Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138 [TBL] [Abstract][Full Text] [Related]
54. LINC01235-TWIST2 feedback loop facilitates epithelial-mesenchymal transition in gastric cancer by inhibiting THBS2. Tan YE; Xing Y; Ran BL; Zhang C; Pan SW; An W; Chen QC; Xu HM Aging (Albany NY); 2020 Nov; 12(24):25060-25075. PubMed ID: 33206629 [TBL] [Abstract][Full Text] [Related]
55. F2RL3 Regulates Epithelial-Mesenchymal Transition and Angiogenesis in Gastric Cancer through the Rap1/MAPK Signaling Pathway. Ma J; Shi Y; Lu Q; Huang D Front Biosci (Landmark Ed); 2024 May; 29(5):177. PubMed ID: 38812308 [TBL] [Abstract][Full Text] [Related]
56. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition. Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473 [TBL] [Abstract][Full Text] [Related]
57. HIGD1B, as a novel prognostic biomarker, is involved in regulating the tumor microenvironment and immune cell infiltration; its overexpression leads to poor prognosis in gastric cancer patients. Wang S; Zhang S; Li X; Li X; Zhao S; Guo J; Wang S; Wang R; Zhang M; Qiu W Front Immunol; 2024; 15():1415148. PubMed ID: 39108265 [TBL] [Abstract][Full Text] [Related]
58. microRNA-665 is down-regulated in gastric cancer and inhibits proliferation, invasion, and EMT by targeting PPP2R2A. Zhang M; Wang S; Yi A; Qiao Y Cell Biochem Funct; 2020 Jun; 38(4):409-418. PubMed ID: 31923339 [TBL] [Abstract][Full Text] [Related]
59. Amino acid metabolism-related genes as potential biomarkers and the role of MATN3 in stomach adenocarcinoma: A bioinformatics, mendelian randomization and experimental validation study. Zhu W; Fu M; Li Q; Chen X; Liu Y; Li X; Luo N; Tang W; Zhang Q; Yang F; Chen Z; Zhang Y; Peng B; Zhang Q; Zhang Y; Peng X; Hu G Int Immunopharmacol; 2024 Dec; 143(Pt 1):113253. PubMed ID: 39353384 [TBL] [Abstract][Full Text] [Related]
60. Noxa inhibits oncogenesis through ZNF519 in gastric cancer and is suppressed by hsa-miR-200b-3p. Shi J; Ding F; Dai D; Song X; Wu X; Yan D; Han X; Tao G; Dai W Sci Rep; 2024 Mar; 14(1):6568. PubMed ID: 38503887 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]